Text size Amgen had aid it expected its acquisition of Horizon Therapeutics to be completed in the first half of 2023. Dreamstime Horizon Therapeutics stock plunged 18% early Tuesday on reports that the Federal Trade Commission is set to challenge Amgen ’s $27.8 billion deal to buy the biotech company. The FTC is expected to … Read more
Text size BridgeBio stock is soaring Monday. Dreamstime BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for an experimental treatment for achondroplasia, the most common type of short-limbed dwarfism. On Monday, BridgeBio (ticker: BBIO) said in a news release that its experimental drug Infigratinib showed … Read more
Amgen Inc. AMGN -2.42% is in advanced talks to buy drug company Horizon Therapeutics HZNP 0.39% PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company was the last of three suitors … Read more
